Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive

Inclusion Criteria: * Pre-menopausal female subjects * Age 18-40 years, inclusive * Body mass index (BMI) 19-30 kg/m2, inclusive * Healthy as determined by pre-study medical history, physical examination, vital signs, complete neurological examination and 12-lead ECG * Negative tests for HBsAg, anti-HCVAb and HIV-1 and HIV-2 Ab at screening * Negative urine pregnancy test at screening and admission to each treatment period. * Using one of the following methods of contraception: double barrier or intrauterine device Exclusion Criteria: * Subjects who have any contra-indication to the use of oral contraceptives * History or presence of clinically relevant diseases, disorders or surgical history * History of alcoholism or drug abuse * Have used medicines within two weeks of admission to first period that may affect the safety or other study assessments, in the investigator's opinion